MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-13-2025
Cytosorbents Corporation ROA Ratio 2011-2026 | CTSO
Annual ROA Ratio Cytosorbents Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -43.74 | -55.23 | -51.89 | -27.43 | -8.71 | -70.36 | -52.56 | -35.1 | -123.16 | -72.25 | -110.07 | -115.62 | -109.71 | -258.26 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -8.71 | -258.26 | -81.01 |
Quarterly ROA Ratio Cytosorbents Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -11.57 | -10.43 | -22.53 | -26.76 | -46.09 | -59.62 | -63.32 | -43.81 | -63.4 | -63.67 | -62.7 | -41.13 | -51.53 | -27.9 | -32.67 | -26.66 | -17.02 | -11.21 | -9.64 | -8.71 | -22.38 | -46.59 | -56.36 | -70.36 | -71.73 | -55.38 | -59.45 | -50.33 | -47.59 | -47.32 | -37.5 | -35.1 | -72.66 | -86.7 | -110.51 | -123.13 | -94.99 | -97.72 | -53.97 | -76.94 | -178.35 | -170.75 | -205.38 | -174.98 | -74.94 | -81.1 | -94.18 | -99.09 | -118.61 | -114.29 | -110.67 | -93.61 | -175.06 | -236.99 | -268.82 | -201.87 | -81.46 | -63.19 | -57.22 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -8.71 | -268.82 | -78.26 |
ROA Ratio of other stocks in the Medical devices industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Abiomed
ABMD
|
15.09 | - | - | $ 17.2 B |  USA |
 |
Acutus Medical
AFIB
|
-151.34 | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
-9.84 | - | 3.58 % | $ 2.21 M | USA |
 |
Apollo Endosurgery
APEN
|
-36.14 | - | - | $ 475 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
-2.42 | $ 9.57 | 0.1 % | $ 687 M |  Israel |
 |
GenMark Diagnostics, Inc.
GNMK
|
-8.34 | - | - | $ 1.77 B | USA |
 |
Alphatec Holdings
ATEC
|
-20.9 | $ 22.65 | -0.15 % | $ 3.24 B | USA |
 |
Lianluo Smart Limited
LLIT
|
-53.6 | - | 24.59 % | $ 44.8 M |  China |
 |
AxoGen
AXGN
|
-4.89 | $ 33.63 | 0.78 % | $ 1.49 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
-9.05 | - | - | $ 3.31 B | USA |
 |
Apyx Medical Corporation
APYX
|
-23.62 | $ 3.5 | 1.16 % | $ 121 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-22.1 | $ 3.66 | -3.56 % | $ 136 M |  France |
 |
Electromed
ELMD
|
14.01 | $ 28.9 | -0.41 % | $ 244 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-116.17 | - | -5.86 % | $ 30.6 M | USA |
 |
Bio-Rad Laboratories
BIO
|
-7.64 | $ 323.76 | 1.47 % | $ 9.13 B | USA |
 |
BioSig Technologies
BSGM
|
-1226.84 | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
4.69 | $ 97.6 | -0.79 % | $ 144 B | USA |
 |
CONMED Corporation
CNMD
|
5.74 | $ 43.07 | -2.56 % | $ 1.33 B | USA |
 |
Conformis
CFMS
|
-53.67 | - | - | $ 16.4 M | USA |
 |
Bruker Corporation
BRKR
|
1.95 | $ 54.12 | 3.12 % | $ 8.06 K | USA |
 |
Abbott Laboratories
ABT
|
16.46 | $ 125.84 | -0.27 % | $ 219 B | USA |
 |
InMode Ltd.
INMD
|
23.07 | $ 14.47 | 1.47 % | $ 1.15 B | Israel |
 |
CryoLife, Inc.
CRY
|
-2.11 | - | -4.14 % | $ 702 M | USA |
 |
IRIDEX Corporation
IRIX
|
-27.79 | $ 1.16 | -2.94 % | $ 18.7 M | USA |
 |
Cardiovascular Systems
CSII
|
-11.45 | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
-16.53 | - | -10.19 % | $ 1.99 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
-323.35 | - | 1.15 % | $ 34.5 M | USA |
|
LENSAR
LNSR
|
-47.37 | $ 11.6 | -0.6 % | $ 134 M | USA |
 |
Soliton, Inc.
SOLY
|
-43.02 | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-86.69 | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-17.05 | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
-8.55 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-37.58 | - | - | $ 111 M |  Canada |
 |
Dynatronics Corporation
DYNT
|
-70.61 | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
-119.24 | - | - | $ 10.2 M | USA |
 |
Orthofix Medical
OFIX
|
-14.1 | $ 15.77 | -2.65 % | $ 601 M |  Curacao |
 |
Intersect ENT, Inc.
XENT
|
-31.81 | - | - | $ 955 M | USA |
 |
Second Sight Medical Products
EYES
|
-56.51 | - | -0.97 % | $ 54.4 M | USA |
 |
GBS
GBS
|
-128.11 | - | -0.57 % | $ 7.12 M | USA |
 |
Align Technology
ALGN
|
6.78 | $ 172.23 | 0.97 % | $ 12.9 B | USA |
 |
Accuray Incorporated
ARAY
|
-0.34 | $ 0.89 | -0.47 % | $ 91.5 M | USA |
 |
IRadimed Corporation
IRMD
|
19.56 | $ 98.81 | -1.19 % | $ 1.25 B | USA |
 |
Avinger
AVGR
|
-133.04 | - | -20.74 % | $ 369 K | USA |
 |
ClearPoint Neuro
CLPT
|
-48.26 | $ 15.06 | -1.63 % | $ 407 M | USA |
 |
FONAR Corporation
FONR
|
6.24 | $ 18.56 | 0.02 % | $ 122 M | USA |
 |
Sintx Technologies
SINT
|
-53.75 | $ 3.78 | -1.32 % | $ 14.1 M | USA |
 |
Sensus Healthcare
SRTS
|
10.69 | $ 4.82 | 8.8 % | $ 78.6 M | USA |
 |
Globus Medical
GMED
|
1.96 | $ 94.0 | -0.66 % | $ 12.8 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
-0.17 | $ 13.69 | -1.23 % | $ 1.05 B | USA |
 |
Stryker Corporation
SYK
|
1.27 | $ 369.46 | 0.61 % | $ 141 B | USA |